US Patent Issued to Massachusetts Eye and Ear Infirmary on Sept. 15 for "RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,707, issued on Sept. 15, was assigned to Massachusetts Eye and Ear Infirmary (Boston).

"RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition" was invented by Leo A. Kim (Boston), Joseph F. Arboleda-Velasquez (Newton, Mass.), Dhanesh Amarnani (Allston, Mass.) and Dean Eliott (Carlsbad, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present subject matter provides compositions. formulations and methods for preventing or reducing proliferation or migration of retinal cells or epithelial to mesenchymal transition in ocular cells or cells from other tissues."

Th...